TCTR20151118004已完成1 期
idocaine spray reduce the pain of colposcopic cervical biopsy: a randomized controlled trial
no0 个研究点目标入组 200 人开始时间: 2015年11月18日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 60 Years（—）
- 性别
- Female
入选标准
- •abnormal cervical screening and colposcopic finding requiring a biopsy
排除标准
- •know history of hypersensitivity to lidocaine or to other components of the solution, pregnancy, post hysterectomy, bleeding disorders, drug abuse, cervical and vaginal infection and inability to read or speak Thai.
研究者
相似试验
招募中
1 期
The efficacy of lidocaine spray in pain relief durring office-based endometrial sampling:A randomized placebo-controlled trialWoman from the age of 35 yrs old Abnormal uterine bleedingAbnormal uterine bleedingPain scoreXylocaine sprayLidocaine sprayNovak curretteEndometrial samplingTCTR20170117001Thammasat university70
已完成
4 期
idocaine injection in mesosalpinx for pain relief during post-partum tubal sterilization in Srinagarind Hospital, Randomize double blindpost partum tubal sterilizationLidocaine injectionPostpartum tubal sterilizationPain reliefSrinagarind hospitalTCTR20150306001Research Affair ,Faculty of Medicine , Khon kaen universityDepartment obstetrics and Gynecology60
已完成
不适用
The use of intravesical lignocaine to reduce pain and increase dwell time of intravesical mitomycin chemotherapyAnalgesia for intravesical mitomycin chemotheapyMalignant neoplasm of bladderCancerISRCTN65454120Department of Health (UK)
已完成
不适用
idocaine Spray for Pain Control during Office-based Endometrial Biopsy: A Randomised Placebo-controlled Trialabnormal uterine bleedinglidocaine,abnormal bleedingTCTR20170714001Research Facilitation Division, Faculty of Medicine Vajira hospital50
已完成
不适用
Efficacy of lidocaine spray in pain reduction during colposcopy-directed cervical biopsy: a randomized controlled trialWomen with abnormal cervical cytology (ASC-US,ASC-H,LSIL)Lidocaine sprayColposcopic directed biopsyPain scoreCervical cancerTCTR20171208001o360